The present disclosure provides novel glucagon-like peptide-1 (GLP-1) receptor modulators such as compounds of Formula (I) or (II), and pharmaceutically acceptable salts thereof. The present disclosure also provides pharmaceutical compositions, kits, and uses that involve the GLP-1 receptor modulators for regulating blood glucose levels and/or treating diabetes via, e.g., modulating the endogenous signaling pathways mediated by the GLP-1 receptor.本發明係提供新穎的胰高血糖素樣肽第一型(GLP-1)受體調控子,如式(I)或(II)之化合物,及其醫藥上可接受鹽類。本發明亦提供涉及GLP-1受體調控子之醫藥組合物、套組、及用途,以經由如調控GLP-1受體媒介之內源性傳訊途徑而調節血糖濃度及/或治療糖尿病。
